BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 9658404)

  • 21. Extracellular simian virus 40 induces an ERK/MAP kinase-independent signalling pathway that activates primary response genes and promotes virus entry.
    Dangoria NS; Breau WC; Anderson HA; Cishek DM; Norkin LC
    J Gen Virol; 1996 Sep; 77 ( Pt 9)():2173-82. PubMed ID: 8811017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A dominant role for the Raf-MEK pathway in forskolin, 12-O-tetradecanoyl-phorbol acetate, and platelet-derived growth factor-induced CREB (cAMP-responsive element-binding protein) activation, uncoupled from serine 133 phosphorylation in NIH 3T3 cells.
    Seternes OM; Johansen B; Moens U
    Mol Endocrinol; 1999 Jul; 13(7):1071-83. PubMed ID: 10406459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis.
    Magi-Galluzzi C; Mishra R; Fiorentino M; Montironi R; Yao H; Capodieci P; Wishnow K; Kaplan I; Stork PJ; Loda M
    Lab Invest; 1997 Jan; 76(1):37-51. PubMed ID: 9010448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of the mitogen-activated protein kinase pathway in U937 leukemic cells induces phosphorylation of the amino terminus of the TATA-binding protein.
    Biggs JR; Ahn NG; Kraft AS
    Cell Growth Differ; 1998 Aug; 9(8):667-76. PubMed ID: 9716183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Essential role of calcium in the regulation of MAP kinase phosphatase-1 expression.
    Scimeca JC; Servant MJ; Dyer JO; Meloche S
    Oncogene; 1997 Aug; 15(6):717-25. PubMed ID: 9264412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta 1 integrin- and proteoglycan-mediated stimulation of T lymphoma cell adhesion and mitogen-activated protein kinase signaling by thrombospondin-1 and thrombospondin-1 peptides.
    Wilson KE; Li Z; Kara M; Gardner KL; Roberts DD
    J Immunol; 1999 Oct; 163(7):3621-8. PubMed ID: 10490955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elk-1 proteins are phosphoproteins and activators of mitogen-activated protein kinase.
    Rao VN; Reddy ES
    Cancer Res; 1993 Aug; 53(15):3449-54. PubMed ID: 8339245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
    Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
    Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct binding determinants for ERK2/p38alpha and JNK map kinases mediate catalytic activation and substrate selectivity of map kinase phosphatase-1.
    Slack DN; Seternes OM; Gabrielsen M; Keyse SM
    J Biol Chem; 2001 May; 276(19):16491-500. PubMed ID: 11278799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repression of the calcitonin gene-related peptide promoter by 5-HT1 receptor activation.
    Durham PL; Sharma RV; Russo AF
    J Neurosci; 1997 Dec; 17(24):9545-53. PubMed ID: 9391009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase.
    Bedecs K; Elbaz N; Sutren M; Masson M; Susini C; Strosberg AD; Nahmias C
    Biochem J; 1997 Jul; 325 ( Pt 2)(Pt 2):449-54. PubMed ID: 9230127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retinoic acid inhibits hepatic Jun N-terminal kinase-dependent signaling pathway in ethanol-fed rats.
    Chung J; Chavez PR; Russell RM; Wang XD
    Oncogene; 2002 Feb; 21(10):1539-47. PubMed ID: 11896582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The dual specificity mitogen-activated protein kinase phosphatase-1 and -2 are induced by the p42/p44MAPK cascade.
    Brondello JM; Brunet A; Pouysségur J; McKenzie FR
    J Biol Chem; 1997 Jan; 272(2):1368-76. PubMed ID: 8995446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular defense against H2O2-induced apoptosis via MAP kinase-MKP-1 pathway.
    Xu Q; Konta T; Nakayama K; Furusu A; Moreno-Manzano V; Lucio-Cazana J; Ishikawa Y; Fine LG; Yao J; Kitamura M
    Free Radic Biol Med; 2004 Apr; 36(8):985-93. PubMed ID: 15059639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delay in serum stimulation of Erk activity caused by oncogenic transformation.
    Greulich H; Reichman C; Hanafusa H
    Oncogene; 1996 Apr; 12(8):1689-95. PubMed ID: 8622889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The activity of the Ets transcription factor PEA3 is regulated by two distinct MAPK cascades.
    O'Hagan RC; Tozer RG; Symons M; McCormick F; Hassell JA
    Oncogene; 1996 Sep; 13(6):1323-33. PubMed ID: 8808707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitogen-activated protein kinase phosphatase-1 (MKP-1) expression is induced by low oxygen conditions found in solid tumor microenvironments. A candidate MKP for the inactivation of hypoxia-inducible stress-activated protein kinase/c-Jun N-terminal protein kinase activity.
    Laderoute KR; Mendonca HL; Calaoagan JM; Knapp AM; Giaccia AJ; Stork PJ
    J Biol Chem; 1999 Apr; 274(18):12890-7. PubMed ID: 10212278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell replication in the arterial wall: activation of signaling pathway following in vivo injury.
    Koyama H; Olson NE; Dastvan FF; Reidy MA
    Circ Res; 1998 Apr; 82(6):713-21. PubMed ID: 9546380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity.
    Bardwell AJ; Abdollahi M; Bardwell L
    Biochem J; 2003 Mar; 370(Pt 3):1077-85. PubMed ID: 12529172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual-specificity protein tyrosine phosphatase VHR down-regulates c-Jun N-terminal kinase (JNK).
    Todd JL; Rigas JD; Rafty LA; Denu JM
    Oncogene; 2002 Apr; 21(16):2573-83. PubMed ID: 11971192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.